Cat.#: ACPP-1212
| Despition | PAX8 Blocking Peptide for Immunodepletion, Immunocompetition |
| SIZE | 250 µg |
| Applications | Immunodepletion & Immunocompetition assay |
| Storage | Store at -20⁰C for long term |
| Shipping | Shipped at 4°C |
| Cat.# | Name | Size | Price |
|---|---|---|---|
| ACPP-1704 | Human CSDC2 Protein (AC1704) | 2 µg | inquiry |
| ACPP-1485 | Rat VEGF C Protein (152 a.a.) (AC1485) | 2 µg | inquiry |
| ACPP-1227 | Pax2 Blocking Peptide (AC1227) | 250 µg | inquiry |
| ACPP-1788 | Human NEUROG3 Protein (AC1788) | 2 µg | inquiry |
| ACPP-1200 | PAX8 Blocking Peptide (AC1200) | 250 µg | inquiry |
| ACPP-1268 | Human LGALS3 Protein (AC1268) | 10 µg | inquiry |
| ACPP-1419 | Human TAC3 Protein (AC1419) | 5 µg | inquiry |
| ACPP-1264 | SorLA Blocking Peptide (AC1264) | 250 µg | inquiry |
| ACPP-1121 | Recombinant Human GFAP Protein (AC1121) | 25 µl | inquiry |
| ACPP-1098 | Synthetic Nanodisc Human CD133 Protein (AC1098) | 10 µg | inquiry |
Ace Therapeutics is a global leading provider of stroke research services. We are committed to accelerating progress in stroke research and drug development.